|
Vivos Therapeutics, Inc. (VVOS) Valoración de DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Vivos Therapeutics, Inc. (VVOS) Bundle
¿Busca evaluar el valor intrínseco de Vivos Therapeutics, Inc.? Nuestra calculadora VVOS DCF integra datos del mundo real con características de personalización integrales, lo que le permite refinar sus pronósticos y mejorar sus opciones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.4 | 13.1 | 16.9 | 16.0 | 13.8 | 14.7 | 15.6 | 16.5 | 17.6 | 18.7 |
| Revenue Growth, % | 0 | 14.68 | 29.23 | -5.1 | -13.87 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| EBITDA | -9.9 | -11.2 | -19.5 | -24.4 | -16.7 | -13.9 | -14.7 | -15.6 | -16.6 | -17.7 |
| EBITDA, % | -86.59 | -86.04 | -115.73 | -152.03 | -120.82 | -94.53 | -94.53 | -94.53 | -94.53 | -94.53 |
| Depreciation | .8 | .7 | .7 | .7 | .6 | .7 | .8 | .8 | .9 | .9 |
| Depreciation, % | 6.59 | 5.49 | 4.34 | 4.17 | 4.5 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 |
| EBIT | -10.6 | -12.0 | -20.3 | -25.0 | -17.3 | -14.2 | -15.1 | -16.0 | -17.0 | -18.1 |
| EBIT, % | -93.18 | -91.54 | -120.07 | -156.21 | -125.32 | -96.94 | -96.94 | -96.94 | -96.94 | -96.94 |
| Total Cash | .5 | 18.2 | 24.0 | 3.5 | 1.6 | 7.0 | 7.4 | 7.9 | 8.4 | 8.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.0 | 1.5 | 1.7 | .5 | .2 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 |
| Account Receivables, % | 8.39 | 11.6 | 10.18 | 2.85 | 1.46 | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 |
| Inventories | .3 | .0 | .0 | .0 | .0 | .1 | .1 | .1 | .1 | .1 |
| Inventories, % | 2.32 | 0.000007653313 | 0 | 0 | 0 | 0.46311 | 0.46311 | 0.46311 | 0.46311 | 0.46311 |
| Accounts Payable | 1.1 | .8 | .9 | 1.4 | 2.1 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Accounts Payable, % | 9.51 | 5.98 | 5.45 | 8.81 | 15.54 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 |
| Capital Expenditure | -.2 | -.1 | -2.4 | -.9 | -.8 | -.8 | -.9 | -.9 | -1.0 | -1.1 |
| Capital Expenditure, % | -1.54 | -0.92033 | -14.19 | -5.77 | -5.82 | -5.65 | -5.65 | -5.65 | -5.65 | -5.65 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -10.8 | -8.8 | -20.3 | -23.8 | -17.3 | -13.3 | -14.1 | -15.0 | -16.0 | -17.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -10.3 | -8.8 | -22.0 | -22.3 | -16.5 | -15.1 | -14.2 | -15.1 | -16.0 | -17.1 |
| WACC, % | 31.26 | 30.95 | 31.26 | 31.2 | 31.26 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -36.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -17 | |||||||||
| Terminal Value | -60 | |||||||||
| Present Terminal Value | -15 | |||||||||
| Enterprise Value | -52 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -52 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | -42.61 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real VVOS financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Vivos Therapeutics' valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life VVOS Financials: Pre-filled historical and projected data for Vivos Therapeutics, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Vivos' intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Vivos' valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring Vivos Therapeutics, Inc. (VVOS) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Immediately see the recalculated results, including Vivos Therapeutics, Inc.'s (VVOS) intrinsic value.
- Step 5: Utilize the outputs to make informed investment decisions or create reports.
Why Choose This Calculator for Vivos Therapeutics, Inc. (VVOS)?
- Accurate Data: Up-to-date Vivos Therapeutics financials provide dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: An intuitive design and clear instructions make it accessible for users of all levels.
Who Should Use This Product?
- Healthcare Professionals: Understand the latest advancements in sleep apnea treatment and apply them in practice.
- Researchers: Utilize data from clinical studies to enhance your research on sleep disorders.
- Investors: Evaluate your investment strategies and analyze market performance for Vivos Therapeutics, Inc. (VVOS).
- Analysts: Optimize your evaluations with a customizable financial model tailored for the healthcare sector.
- Patients: Learn about innovative treatment options for sleep apnea and their potential benefits.
What the Template Contains
- Historical Data: Includes Vivos Therapeutics, Inc.’s (VVOS) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Vivos Therapeutics, Inc.’s (VVOS) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital specific to Vivos Therapeutics, Inc. (VVOS).
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions tailored for Vivos Therapeutics, Inc. (VVOS).
- Quarterly and Annual Statements: A complete breakdown of Vivos Therapeutics, Inc.’s (VVOS) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically for Vivos Therapeutics, Inc. (VVOS).